Liarozole
Appearance
![]() | |
Names | |
---|---|
Preferred IUPAC name
6-[(3-Chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-1,3-benzimidazole | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChemCID
|
|
UNII | |
CompTox Dashboard(EPA)
|
|
| |
| |
Properties | |
C17H13ClN4 | |
Molar mass | 308.77g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).
|
Liarozoleis aretinoic acidmetabolism-blocking drug andaromatase inhibitor.[1]Liarozole is anisomerofalprazolam,but the two compounds are completely unrelated.
References[edit]
- ^Vahlquist, A; Blockhuys, S; Steijlen, P; Van Rossem, K; Didona, B; Blanco, D; Traupe, H (2013)."Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial".The British Journal of Dermatology.170(1): 173–81.doi:10.1111/bjd.12626.PMC4232915.PMID24102348.